Position in VYGR
as of Jun 30, 2024
· filed Aug 14, 2024
Position Value
$2,373,000
-$420,000 QoQ
Shares Held
300,000
0.0% QoQ
Ownership
0.497%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025Woodline Partners LP holds $3,037,879,092 across 178 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,500,895 | $199,196,286 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,408,772 | $123,042,146 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,648,428 | $104,741,115 | |
| 4 | RCUS |
Arcus Biosciences, Inc.
|
3,769,788 | $89,834,048 | |
| 5 | TNGX |
Tango Therapeutics, Inc.
|
10,072,225 | $89,239,913 | |
| 6 | IRON |
Disc Medicine, Inc.
|
957,833 | $76,061,518 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
688,779 | $73,726,904 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
125,659 | $73,176,262 |
All Filings in VYGR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2024-06-30 | $2,373,000 | 300,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,793,000 | 300,000 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||